Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
Patents for C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
11/2009
11/17/2009CA2521950C Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
11/12/2009US20090281087 Compounds II
11/11/2009EP2114948A2 Inhibitors of poly(adp-ribose)polymerase
11/11/2009CN100558428C Calcitonin gene related peptide receptor antagonists
11/10/2009US7615554 Erastin and erastin binding proteins, and uses thereof
11/10/2009US7615550 Such as 1-(4-{[1-(1-methylethyl)-4-piperidinyl]oxy}phenyl)-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine; neurodegenerative disorders including Alzheimer's disease; allergic rhinitis
11/05/2009WO2009102460A3 Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/05/2009WO2009100996A3 Process for preparing pyrazole functionalized benzodiazepinones
11/05/2009US20090275727 Peptide turn mimetics
11/05/2009US20090275564 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
11/03/2009CA2443724C Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
11/03/2009CA2360767C Tricyclic benzodiazepines as vasopressin receptor antagonists
10/2009
10/29/2009WO2009110942A3 Generation of combinatorial synthetic libraries and screening for novel proadhesins and nonadhesins
10/29/2009US20090270613 5-Fluoro-4-methyl-2-{2-[4-(4-methyl-piperazin-1-yl)-butoxy]-pyridin-4-yl}-1H-benzoimidazole; leukocyte recruitment inhibition, modulating H4 receptor, and treating conditions such as inflammation
10/29/2009US20090270612 Therapeutic Agent for Osteoporosis Using a Retinoid X Receptor-Related Compound
10/29/2009US20090270611 Benzoimidazole compounds
10/27/2009CA2392057C Calcium salts of 1,5-benzodiazepine derivatives, process for producing the salts and drugs containing the same
10/27/2009CA2341434C Pyrrolobenzodiazepine compounds
10/22/2009WO2009102428A3 1,3-OXAZEPAN-2-ONE AND 1,3-DIAZEPAN-2-ONE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1
10/22/2009US20090264648 Synthesis of pyrazoles
10/22/2009US20090264646 Benzoimidazole compounds
10/22/2009US20090264645 Benzoimidazole compounds
10/22/2009US20090264419 CYCLIC MALONAMIDES AS INHIBITORS OF Abeta PROTEIN PRODUCTION
10/22/2009US20090264418 such as [5-(4-cyclopentyl-piperazine-1-carbonyl)-1H-indol-2-yl]-pyrrolidin-1-yl-methanone, useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors
10/22/2009US20090264416 N-benzyl,n'-arylcarbonylpiperazine derivatives
10/22/2009US20090264415 Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment
10/22/2009US20090264406 3-methyl-imidazo[1,2-b]pyridazine derivatives
10/22/2009US20090264404 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders
10/22/2009US20090263886 Farnesyl dibenzodiazepinone and processes for its production
10/21/2009EP1608374B9 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
10/21/2009EP1346993B1 Lactam compounds and medical use thereof
10/21/2009CN100551915C 8-chloro-2,3-benzodiazepine derivatives
10/20/2009US7605261 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use
10/20/2009US7605155 Enzyme inhibitors from pyrazolo[1,5a]pyrimidine as enzyme inhibitors; cyclin dependent kinases (CDKs) inhibitors; cancer, inflammation and arthritis; neurodegenerative diseases such Alzheimer's; cardiovascular, viral and fungal diseases
10/15/2009WO2009093269A9 Novel heterocyclic compounds
10/15/2009US20090258857 Chemical compounds
10/13/2009US7601713 Kinase inhibitors and their uses
10/13/2009US7601711 Such as [5-(4-cyclopentyl-piperazine-1-carbonyl)-1H-indol-2-yl]-morpholin-4-yl-methanone; histamine H3-antagonists
10/13/2009CA2473070C Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection
10/13/2009CA2386974C Benzodiazepine derivatives for use in acute or chronic neurological disorders
10/08/2009US20090253908 Novel m3 muscarinic acetylchoine receptor antagonists
10/08/2009US20090253686 Unsolvated benzodiazepine compositions and methods
10/08/2009US20090253685 Product comprising at least one Cdc25 phosphatase inhibitor in combination with at least one other anti-cancer agent
10/08/2009US20090253684 Leukotriene b4 inhibitors
10/08/2009US20090253683 7-membered ring compound and method of production and pharmaceutical application thereof
10/08/2009US20090253680 Selected cgrp-antagonists, processes for preparing them and their use as pharmaceutical compositions
10/08/2009US20090253670 nicotinic receptor modulators such as N-[3-(1H-pyrrol-1-yl)benzyl]-4-[(trifluoromethyl)thio]benzamide, useful for treating and preventing a condition or disorder affecting cognition, neurodegeneration and schizophrenia
10/06/2009US7598268 Vascular endothelial growth factor; tyrosine kinase inhibitor;angiogenesis inhibitor; anticarcinogenic agents
10/06/2009US7598237 7-aryl 1,5-dihydro-4,1-benzoxazepin-2(3H)-one derivatives and their use as progesterone receptor modulators
10/01/2009WO2009119528A1 Heterocyclic compound
09/2009
09/29/2009CA2310850C A covalent conjugate of clozapine with a fatty acid and its use for treating schizophrenia
09/24/2009US20090239848 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE
09/24/2009US20090239846 Novel Compounds
09/23/2009EP1467989B1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection
09/23/2009EP1461038B9 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
09/23/2009CN101541768A P2X4 receptor antagonist
09/17/2009US20090233913 Optical isomers of dihydro-2,3-benzodiazepines and their stereoselective synthesis
09/17/2009US20090233910 Npy antagonists, preparation and uses
09/17/2009US20090233907 Pyridopyrimidine Derivatives and Their Use as PDE4 Inhibitors
09/10/2009US20090227566 Such as N-(4-Chlorophenyl)-2-[4-(N,N-dimethylamino)-2-(piperidin-4-yloxy)-benzoylamino]benzamide; Factor Xa inhibitors
09/10/2009US20090227565 Biphenyl Vasopressin Agonists
09/10/2009US20090227561 Fused heterocyclic derivative and use thereof
09/08/2009CA2520901C Pyrene-linked pyrrolo (2,1-c) (1,4) benzodiazepine derivatives useful as anticancer agents
09/03/2009WO2009105825A1 3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists
09/03/2009WO2009105824A1 Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor
09/03/2009WO2009105823A1 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists
09/03/2009US20090221561 Cell Migration Modulating Compounds
09/03/2009US20090221559 Benzodiazepines as hcv inhibitors
09/03/2009US20090221557 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists
09/03/2009US20090221556 Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods
09/03/2009CA2716316A1 Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor
09/03/2009CA2716256A1 3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists
09/03/2009CA2716250A1 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists
09/01/2009US7582624 Benzodiazepine derivatives and pharmaceutical compositions containing them
08/2009
08/27/2009WO2009104819A1 Benzodiazepine compound and pharmaceutical composition
08/27/2009WO2007079003A3 Amide inhibitors of leukotriene a4 hydrolase
08/27/2009US20090215752 Compounds, preparation and therapeutic use thereof
08/27/2009US20090215627 Crystal Structure of Biotin Carboxylase (Bc) Domain of Acetyl-Coenzyme a Carboxylase and Methods of Use Thereof
08/27/2009US20090214465 Quinoxaline Derivatives as Antitumor Agents
08/27/2009CA2715872A1 Benzodiazepine compound and pharmaceutical composition
08/26/2009EP2091929A1 Agents that disrupt cellular replication and their use in inhibiting pathological conditions
08/26/2009CN101516859A 4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]diazepine derivatives
08/25/2009US7579469 For therapy of disease characterized by inflammatory, allergic, or proliferative processes
08/20/2009WO2009102460A2 Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
08/20/2009WO2009100996A2 Process for preparing pyrazole functionalized benzodiazepinones
08/20/2009US20090209473 Componds and methods for pormoting angiogenesis
08/20/2009US20090208413 Registry Method and Control System for Dea Schedule II-V Medicines
08/20/2009CA2715290A1 Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
08/19/2009CN101511806A New heterocyclic compounds containing nitrogen atoms or pharmaceutically acceptable salts thereof, process for the preparation thereof and pharmaceutical composition comprising the same for treatment
08/19/2009CN101511785A Substituted benzyl amine compounds
08/18/2009US7576076 1-Methyl,2,6-dioxo,4-(4-(ethyloxycarbony)piperazin-1-yl-),5-(3-trifluoromethylphenyl)methyl-)-1,2,3,6-tetrahydropyrimidine; antagonist, antagonism; psychoses; antidepressants; schizophrenia; psychological disorders; Alzheimer's disease; neurodegenerative diseases;drug abuse, drug dependence (cocaine)
08/18/2009CA2495721C Non-nucleoside reverse transcriptase inhibitors
08/18/2009CA2479216C Dipyridodiazepinones as reverse transcriptase inhibitors
08/13/2009US20090203901 Process for preparing pyrazole functionalized benzodiazepinones
08/13/2009US20090203657 Dual Pharmacophores - PDE4-Muscarinic Antagonistics
08/12/2009CN101506196A Compound that can inhibit UBC13-UEV interactions, pharmaceutical compositions and therapeutic uses
08/12/2009CN101503394A High piperazine acetydrazide derivatives, and preparation and use thereof
08/11/2009US7572788 Compositions and methods relating to novel compounds and targets thereof
08/11/2009US7572787 Substituted naphthalene sulfonamides
08/11/2009CA2395846C Diazepan derivatives or salts thereof
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 ... 60